Aditxt, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aditxt, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-03-31 was $168.30K, a 4425.41% increase year-over-year.
- Aditxt, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $250.00K.
- Aditxt, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-03-31 was $3.72K.
- Aditxt, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $507.56K, a 51.01% increase from fiscal 2021.
- Aditxt, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $336.12K, a 4.71% increase from fiscal 2020.
- Aditxt, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2020 was $321.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2023-03-31 | $168.30K 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $507.56K 10-K · filed 2023-04-17 | |
| 2022-06-30 | $250.00K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $3.72K 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $336.12K 10-K · filed 2023-04-17 | |
| 2020-12-31 | $321.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |